BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22082152)

  • 1. MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS.
    Venneti S; Boateng LA; Friedman JR; Baldwin DA; Tobias JW; Judkins AR; Mourelatos Z; Lal P
    Brain Pathol; 2012 Jul; 22(4):522-9. PubMed ID: 22082152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
    Carney EM; Banerjee P; Ellis CL; Albadine R; Sharma R; Chaux AM; Burger PC; Netto GJ
    Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastases to hemangioblastomas in von Hippel-Lindau disease.
    Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
    J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
    Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
    Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM
    Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cerebellar Tumor-to-Tumor Metastasis in a Patient With Von Hippel-Lindau Disease.
    Wang T; Liu L; Rampisela D; Dong X; Keith KA; Benardete EA; Shan FY
    Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):244-248. PubMed ID: 38712587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
    Munari E; Marchionni L; Chitre A; Hayashi M; Martignoni G; Brunelli M; Gobbo S; Argani P; Allaf M; Hoque MO; Netto GJ
    Hum Pathol; 2014 Jun; 45(6):1130-8. PubMed ID: 24703100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas.
    Brown DF; Gazdar AF; White CL; Yashima K; Shay JW; Rushing EJ
    J Neuropathol Exp Neurol; 1997 Dec; 56(12):1349-55. PubMed ID: 9413283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis of renal cell carcinoma to central nervous system hemangioblastoma in two patients with von Hippel-Lindau disease.
    Hamazaki S; Nakashima H; Matsumoto K; Taguchi K; Okada S
    Pathol Int; 2001 Dec; 51(12):948-53. PubMed ID: 11844068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
    Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
    Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
    Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary hemangioblastoma of the kidney with molecular analyses by next generation sequencing: a case report and review of the literature.
    Wang X; Haines GK; Mehrotra M; Houldsworth J; Si Q
    Diagn Pathol; 2022 Feb; 17(1):34. PubMed ID: 35220972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma.
    Heinzelmann J; Henning B; Sanjmyatav J; Posorski N; Steiner T; Wunderlich H; Gajda MR; Junker K
    World J Urol; 2011 Jun; 29(3):367-73. PubMed ID: 21229250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
    Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
    Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
    Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
    Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum microRNA Expression Profiling: Potential Diagnostic Implications of a Panel of Serum microRNAs for Clear Cell Renal Cell Cancer.
    Yadav S; Khandelwal M; Seth A; Saini AK; Dogra PN; Sharma A
    Urology; 2017 Jun; 104():64-69. PubMed ID: 28336290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC.
    Szabó Z; Szegedi K; Gombos K; Mahua C; Flaskó T; Harda K; Halmos G
    Urol Oncol; 2016 Dec; 34(12):533.e21-533.e27. PubMed ID: 27427222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.